10233 tests performed with 25779 sites detected as adaptive and 707544 as nearly-neutral.
\scriptsize
\begin{longtable}{lrrrrr}
\toprule
                                     Gene Ontology & $n_{\mathrm{Observed}}$ & $n_{\mathrm{Expected}}$ & Odds ratio & $p_{\mathrm{value}}$ & $e_{\mathrm{value}}$ \\
\midrule
\endhead
\midrule
\multicolumn{6}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                             extracellular exosome &                    5825 &                  2976.1 &      1.957 &                    0 &                    0 \\
                           lipid metabolic process &                    1968 &                   793.4 &      2.480 &        9.7e$^{-245}$ &        9.9e$^{-241}$ \\
                                   plasma membrane &                    8874 &                  5667.0 &      1.566 &        1.6e$^{-234}$ &        1.7e$^{-230}$ \\
                       oxidation-reduction process &                    1870 &                   759.8 &      2.461 &        8.7e$^{-230}$ &        8.9e$^{-226}$ \\
                           oxidoreductase activity &                    1634 &                   676.3 &      2.416 &        4.6e$^{-195}$ &        4.7e$^{-191}$ \\
                                          membrane &                   13010 &                  8990.2 &      1.447 &        5.4e$^{-186}$ &        5.5e$^{-182}$ \\
                             endoplasmic reticulum &                    2933 &                  1693.4 &      1.732 &        2.7e$^{-144}$ &        2.7e$^{-140}$ \\
             integral component of plasma membrane &                    3102 &                  1840.1 &      1.686 &        2.7e$^{-138}$ &        2.8e$^{-134}$ \\
                               blood microparticle &                     625 &                   181.1 &      3.451 &        3.3e$^{-136}$ &        3.4e$^{-132}$ \\
                    integral component of membrane &                    8963 &                  6402.1 &      1.400 &        9.3e$^{-136}$ &        9.5e$^{-132}$ \\
                      fatty acid metabolic process &                     772 &                   274.7 &      2.810 &        3.8e$^{-124}$ &        3.9e$^{-120}$ \\
                                     ion transport &                    1441 &                   701.0 &      2.055 &        1.1e$^{-121}$ &        1.2e$^{-117}$ \\
                           transmembrane transport &                    1468 &                   753.6 &      1.948 &          5e$^{-108}$ &        5.1e$^{-104}$ \\
                                 metabolic process &                    1316 &                   665.7 &      1.977 &        2.9e$^{-101}$ &           3e$^{-97}$ \\
                                     myelin sheath &                     310 &                    64.6 &      4.802 &         1.3e$^{-99}$ &         1.3e$^{-95}$ \\
                                        melanosome &                     353 &                    87.0 &      4.057 &         6.6e$^{-95}$ &         6.8e$^{-91}$ \\
                       ion transmembrane transport &                     726 &                   294.0 &      2.469 &         1.7e$^{-93}$ &         1.8e$^{-89}$ \\
                                catalytic activity &                    1299 &                   681.6 &      1.906 &         9.4e$^{-91}$ &         9.6e$^{-87}$ \\
                                      drug binding &                     436 &                   133.5 &      3.266 &         3.5e$^{-89}$ &         3.5e$^{-85}$ \\
                                lysosomal membrane &                     924 &                   428.8 &      2.155 &         4.3e$^{-89}$ &         4.4e$^{-85}$ \\
                                     mitochondrion &                    2578 &                  1669.9 &      1.544 &         1.1e$^{-83}$ &         1.2e$^{-79}$ \\
                 protein homodimerization activity &                    1464 &                   823.3 &      1.778 &         5.6e$^{-83}$ &         5.7e$^{-79}$ \\
 positive regulation of G-protein coupled recep... &                     155 &                    17.6 &      8.800 &         3.4e$^{-81}$ &         3.4e$^{-77}$ \\
                      fatty acid synthase activity &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 acyl-carrier-protein S-malonyltransferase acti... &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
      acyl-acyl-carrier-protein hydrolase activity &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
       enoyl-acyl-carrier-protein reductase (NADPH &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 3-oxoacyl-acyl-carrier-protein reductase (NADP... &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 3-hydroxyacyl-acyl-carrier-protein dehydratase... &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
       enoyl-acyl-carrier-protein reductase (NADPH &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
    oleoyl-acyl-carrier-protein hydrolase activity &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 3-hydroxypalmitoyl-acyl-carrier-protein dehydr... &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 acyl-carrier-protein S-acetyltransferase activity &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 3-oxo-glutaryl-acp methyl ester reductase acti... &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 3-oxo-pimeloyl-acp methyl ester reductase acti... &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 myristoyl-acyl-carrier-protein hydrolase activity &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 3-hydroxyoctanoyl-acyl-carrier-protein dehydra... &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
                        phosphopantetheine binding &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
 palmitoyl-acyl-carrier-protein hydrolase activity &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
  3-oxoacyl-acyl-carrier-protein synthase activity &                     134 &                    12.0 &       11.1 &         8.9e$^{-81}$ &         9.1e$^{-77}$ \\
                          neutrophil degranulation &                    1099 &                   570.2 &      1.927 &         6.8e$^{-80}$ &           7e$^{-76}$ \\
                                  glycogen granule &                     135 &                    13.1 &       10.3 &           4e$^{-78}$ &         4.1e$^{-74}$ \\
                    pantothenate metabolic process &                     139 &                    14.3 &      9.730 &         1.3e$^{-77}$ &         1.4e$^{-73}$ \\
                     receptor-mediated endocytosis &                     776 &                   357.3 &      2.172 &         9.8e$^{-77}$ &           1e$^{-72}$ \\
                                symporter activity &                     408 &                   132.9 &      3.071 &           1e$^{-76}$ &           1e$^{-72}$ \\
    regulation of cholesterol biosynthetic process &                     274 &                    65.8 &      4.163 &         2.4e$^{-76}$ &         2.5e$^{-72}$ \\
          anion transmembrane transporter activity &                      90 &                   3.777 &       23.8 &         2.6e$^{-76}$ &         2.7e$^{-72}$ \\
             sodium:bicarbonate symporter activity &                      90 &                   3.777 &       23.8 &         2.6e$^{-76}$ &         2.7e$^{-72}$ \\
                inorganic anion exchanger activity &                      90 &                   3.777 &       23.8 &         2.6e$^{-76}$ &         2.7e$^{-72}$ \\
                              sodium ion transport &                     440 &                   153.0 &      2.876 &         8.7e$^{-75}$ &           9e$^{-71}$ \\
                auditory receptor cell development &                      74 &                   1.889 &       39.2 &         3.3e$^{-73}$ &         3.3e$^{-69}$ \\
                                     NADPH binding &                     148 &                    18.7 &      7.927 &         1.5e$^{-72}$ &         1.5e$^{-68}$ \\
                    endoplasmic reticulum membrane &                    1708 &                  1045.5 &      1.634 &         6.3e$^{-72}$ &         6.4e$^{-68}$ \\
                           muscle filament sliding &                      99 &                   6.535 &       15.1 &         5.2e$^{-70}$ &         5.4e$^{-66}$ \\
               fatty-acyl-CoA biosynthetic process &                     147 &                    19.4 &      7.579 &         6.6e$^{-70}$ &         6.7e$^{-66}$ \\
                cellular response to interleukin-4 &                     140 &                    17.5 &      8.010 &         3.3e$^{-69}$ &         3.4e$^{-65}$ \\
                                   lysosomal lumen &                     517 &                   208.8 &      2.477 &         7.8e$^{-68}$ &           8e$^{-64}$ \\
                                  iron ion binding &                     435 &                   160.0 &      2.718 &         1.4e$^{-67}$ &         1.4e$^{-63}$ \\
                                          lysosome &                     938 &                   491.7 &      1.908 &         6.6e$^{-67}$ &         6.7e$^{-63}$ \\
                transmembrane transporter activity &                     360 &                   118.8 &      3.030 &         1.1e$^{-66}$ &         1.1e$^{-62}$ \\
 positive regulation of cellular metabolic process &                     158 &                    24.7 &      6.401 &         2.7e$^{-66}$ &         2.8e$^{-62}$ \\
                      acetyl-CoA metabolic process &                     158 &                    24.7 &      6.401 &         2.7e$^{-66}$ &         2.8e$^{-62}$ \\
     negative regulation of endopeptidase activity &                     445 &                   168.0 &      2.649 &         3.4e$^{-66}$ &         3.5e$^{-62}$ \\
                               extracellular space &                    2920 &                  2039.2 &      1.432 &         8.2e$^{-66}$ &         8.4e$^{-62}$ \\
   positive regulation of apoptotic cell clearance &                     114 &                    11.2 &       10.2 &         1.2e$^{-65}$ &         1.3e$^{-61}$ \\
  positive regulation of type IIa hypersensitivity &                     114 &                    11.2 &       10.2 &         1.2e$^{-65}$ &         1.3e$^{-61}$ \\
   C5L2 anaphylatoxin chemotactic receptor binding &                     114 &                    11.2 &       10.2 &         1.2e$^{-65}$ &         1.3e$^{-61}$ \\
                         identical protein binding &                    1736 &                  1099.2 &      1.579 &         3.4e$^{-64}$ &         3.5e$^{-60}$ \\
          positive regulation of glucose transport &                     114 &                    11.8 &      9.636 &         1.3e$^{-63}$ &         1.3e$^{-59}$ \\
                                 chaperone binding &                     362 &                   124.9 &      2.897 &         1.1e$^{-62}$ &         1.1e$^{-58}$ \\
                                    lyase activity &                     479 &                   197.9 &      2.421 &         2.1e$^{-60}$ &         2.1e$^{-56}$ \\
                                   anion transport &                     100 &                   9.258 &       10.8 &         8.8e$^{-60}$ &           9e$^{-56}$ \\
                            phospholipid transport &                     283 &                    87.2 &      3.245 &           3e$^{-58}$ &         3.1e$^{-54}$ \\
   regulation of triglyceride biosynthetic process &                     118 &                    15.2 &      7.761 &         2.1e$^{-57}$ &         2.1e$^{-53}$ \\
                           azurophil granule lumen &                     211 &                    52.9 &      3.986 &         1.6e$^{-56}$ &         1.6e$^{-52}$ \\
                              biosynthetic process &                     230 &                    62.1 &      3.703 &           2e$^{-56}$ &         2.1e$^{-52}$ \\
                            apical plasma membrane &                    1222 &                   734.4 &      1.664 &         2.4e$^{-56}$ &         2.5e$^{-52}$ \\
                              mitochondrial matrix &                     709 &                   359.8 &      1.971 &         6.5e$^{-56}$ &         6.6e$^{-52}$ \\
                         DNA topoisomerase binding &                      65 &                   2.762 &       23.5 &         2.4e$^{-55}$ &         2.5e$^{-51}$ \\
                                      angiogenesis &                     917 &                   510.2 &      1.797 &         2.7e$^{-55}$ &         2.8e$^{-51}$ \\
                         steroid metabolic process &                     381 &                   147.1 &      2.590 &         7.6e$^{-55}$ &         7.8e$^{-51}$ \\
                     anion transmembrane transport &                     135 &                    22.2 &      6.081 &         1.1e$^{-54}$ &         1.1e$^{-50}$ \\
                                      phagocytosis &                     186 &                    43.2 &      4.303 &         2.3e$^{-54}$ &         2.3e$^{-50}$ \\
                                hydrolase activity &                    3246 &                  2395.1 &      1.355 &         5.1e$^{-53}$ &         5.2e$^{-49}$ \\
                              transporter activity &                     493 &                   221.1 &      2.230 &           1e$^{-52}$ &         1.1e$^{-48}$ \\
                cellular protein metabolic process &                     792 &                   427.6 &      1.852 &         1.5e$^{-52}$ &         1.5e$^{-48}$ \\
                           secretory granule lumen &                     329 &                   120.0 &      2.742 &         1.9e$^{-52}$ &         1.9e$^{-48}$ \\
                         citrate metabolic process &                      45 &                   0.618 &       72.8 &         1.5e$^{-51}$ &         1.5e$^{-47}$ \\
                               locomotory behavior &                     273 &                    89.6 &      3.045 &         1.7e$^{-51}$ &         1.7e$^{-47}$ \\
                   fatty acid biosynthetic process &                     295 &                   102.2 &      2.886 &         3.3e$^{-51}$ &         3.4e$^{-47}$ \\
                       endoplasmic reticulum lumen &                    1119 &                   677.0 &      1.653 &           1e$^{-50}$ &           1e$^{-46}$ \\
                               calcium ion binding &                    1951 &                  1337.6 &      1.459 &         1.8e$^{-50}$ &         1.8e$^{-46}$ \\
                                     titin binding &                      69 &                   4.361 &       15.8 &         2.8e$^{-50}$ &         2.9e$^{-46}$ \\
 positive regulation of activation of membrane ... &                     127 &                    22.0 &      5.766 &         2.1e$^{-49}$ &         2.2e$^{-45}$ \\
                  endopeptidase inhibitor activity &                     215 &                    61.8 &      3.482 &         4.7e$^{-49}$ &         4.9e$^{-45}$ \\
 positive regulation of fast-twitch skeletal mu... &                      53 &                   1.782 &       29.7 &         5.5e$^{-49}$ &         5.6e$^{-45}$ \\
                            amyloid-beta clearance &                     126 &                    22.3 &      5.655 &         3.1e$^{-48}$ &         3.1e$^{-44}$ \\
                                      brush border &                     430 &                   189.2 &      2.273 &         3.6e$^{-48}$ &         3.7e$^{-44}$ \\
                       basolateral plasma membrane &                     543 &                   265.1 &      2.048 &         9.2e$^{-48}$ &         9.4e$^{-44}$ \\
                             extracellular vesicle &                     313 &                   118.4 &      2.644 &         4.2e$^{-47}$ &         4.3e$^{-43}$ \\
                                  receptor binding &                     872 &                   503.7 &      1.731 &         5.9e$^{-47}$ &           6e$^{-43}$ \\
                             complement activation &                     190 &                    52.0 &      3.654 &         3.1e$^{-46}$ &         3.2e$^{-42}$ \\
                  external side of plasma membrane &                     666 &                   356.7 &      1.867 &         1.1e$^{-45}$ &         1.1e$^{-41}$ \\
                             calcium ion transport &                     360 &                   149.3 &      2.411 &         1.2e$^{-45}$ &         1.2e$^{-41}$ \\
                           aminopeptidase activity &                     170 &                    43.5 &      3.911 &         5.6e$^{-45}$ &         5.7e$^{-41}$ \\
                                    focal adhesion &                     875 &                   514.4 &      1.701 &         1.7e$^{-44}$ &         1.8e$^{-40}$ \\
                 sphingolipid biosynthetic process &                     141 &                    31.0 &      4.551 &           4e$^{-44}$ &         4.1e$^{-40}$ \\
                                organelle membrane &                     291 &                   110.6 &      2.632 &         1.3e$^{-43}$ &         1.3e$^{-39}$ \\
                                           vesicle &                     348 &                   145.7 &      2.388 &           2e$^{-43}$ &           2e$^{-39}$ \\
                     cholesterol metabolic process &                     355 &                   150.5 &      2.359 &         3.1e$^{-43}$ &         3.2e$^{-39}$ \\
 negative regulation of potassium ion transmemb... &                      48 &                   1.782 &       26.9 &         3.5e$^{-43}$ &         3.6e$^{-39}$ \\
           blood vessel endothelial cell migration &                      76 &                   7.849 &      9.683 &         3.8e$^{-43}$ &         3.9e$^{-39}$ \\
                         peptide catabolic process &                     149 &                    35.5 &      4.200 &         7.4e$^{-43}$ &         7.6e$^{-39}$ \\
       high-density lipoprotein particle clearance &                     177 &                    48.8 &      3.625 &         8.6e$^{-43}$ &         8.7e$^{-39}$ \\
                           cholesterol homeostasis &                     243 &                    84.0 &      2.894 &         9.6e$^{-43}$ &         9.8e$^{-39}$ \\
      high-density lipoprotein particle remodeling &                     111 &                    19.7 &      5.641 &         1.2e$^{-42}$ &         1.3e$^{-38}$ \\
                                cholesterol efflux &                     159 &                    40.5 &      3.928 &         2.1e$^{-42}$ &         2.1e$^{-38}$ \\
 positive regulation of transcription of nuclea... &                      80 &                   9.265 &      8.634 &         2.6e$^{-42}$ &         2.6e$^{-38}$ \\
                        endocytic vesicle membrane &                     247 &                    87.0 &      2.840 &         3.5e$^{-42}$ &         3.6e$^{-38}$ \\
                                fibrinogen complex &                     150 &                    36.9 &      4.070 &           1e$^{-41}$ &         1.1e$^{-37}$ \\
             maintenance of mitochondrion location &                      70 &                   6.760 &       10.4 &           2e$^{-41}$ &         2.1e$^{-37}$ \\
                              phospholipid binding &                     331 &                   138.7 &      2.387 &         2.3e$^{-41}$ &         2.3e$^{-37}$ \\
                             inflammatory response &                     869 &                   524.5 &      1.657 &           2e$^{-40}$ &           2e$^{-36}$ \\
                        lipid biosynthetic process &                     115 &                    22.6 &      5.085 &         2.6e$^{-40}$ &         2.7e$^{-36}$ \\
                     relaxation of skeletal muscle &                      37 &                   0.691 &       53.5 &         3.4e$^{-40}$ &         3.5e$^{-36}$ \\
                      isocitrate metabolic process &                      43 &                   1.491 &       28.8 &         1.1e$^{-39}$ &         1.2e$^{-35}$ \\
                      mitochondrial inner membrane &                     620 &                   341.0 &      1.818 &         1.3e$^{-39}$ &         1.3e$^{-35}$ \\
                         mammary gland development &                     172 &                    50.1 &      3.432 &         6.1e$^{-39}$ &         6.3e$^{-35}$ \\
                        retinoid metabolic process &                     363 &                   164.0 &      2.214 &         7.4e$^{-39}$ &         7.6e$^{-35}$ \\
                                hydrolase activity &                     230 &                    81.8 &      2.813 &         7.5e$^{-39}$ &         7.7e$^{-35}$ \\
                                   ruffle assembly &                      58 &                   4.545 &       12.8 &         1.5e$^{-38}$ &         1.5e$^{-34}$ \\
 positive regulation of endoplasmic reticulum c... &                      41 &                   1.346 &       30.5 &         1.6e$^{-38}$ &         1.6e$^{-34}$ \\
                               clathrin-coated pit &                     322 &                   139.3 &      2.311 &         7.1e$^{-38}$ &         7.2e$^{-34}$ \\
                    metalloaminopeptidase activity &                     154 &                    42.3 &      3.638 &         1.2e$^{-37}$ &         1.2e$^{-33}$ \\
                                        chemotaxis &                     337 &                   149.5 &      2.254 &         1.4e$^{-37}$ &         1.4e$^{-33}$ \\
                               apical part of cell &                     454 &                   228.5 &      1.987 &         1.7e$^{-37}$ &         1.7e$^{-33}$ \\
                      steroid biosynthetic process &                     165 &                    48.1 &      3.433 &         1.9e$^{-37}$ &         1.9e$^{-33}$ \\
                    regulation of intracellular pH &                     135 &                    33.5 &      4.026 &         2.7e$^{-37}$ &         2.8e$^{-33}$ \\
         regulation of ion transmembrane transport &                     297 &                   125.3 &      2.370 &         7.4e$^{-37}$ &         7.5e$^{-33}$ \\
                                        sarcolemma &                     365 &                   170.4 &      2.142 &         2.2e$^{-36}$ &         2.2e$^{-32}$ \\
                       vitamin D metabolic process &                     241 &                    91.8 &      2.627 &         2.4e$^{-36}$ &         2.4e$^{-32}$ \\
                             complement activation &                     208 &                    73.0 &      2.851 &         4.7e$^{-36}$ &         4.8e$^{-32}$ \\
                             complement activation &                     239 &                    91.2 &      2.620 &         6.4e$^{-36}$ &         6.5e$^{-32}$ \\
                                cholesterol import &                      84 &                    13.3 &      6.317 &         9.2e$^{-36}$ &         9.4e$^{-32}$ \\
               calcium ion transmembrane transport &                     344 &                   158.3 &      2.174 &         1.6e$^{-35}$ &         1.6e$^{-31}$ \\
                                      phagocytosis &                      84 &                    13.5 &      6.231 &         2.1e$^{-35}$ &         2.2e$^{-31}$ \\
                               mRNA 5'-UTR binding &                      74 &                    10.1 &      7.298 &         3.4e$^{-35}$ &         3.5e$^{-31}$ \\
          low-density lipoprotein particle binding &                     194 &                    66.2 &      2.931 &         3.5e$^{-35}$ &         3.6e$^{-31}$ \\
         positive regulation of peptidase activity &                     106 &                    22.4 &      4.731 &         6.6e$^{-35}$ &         6.8e$^{-31}$ \\
         mitochondrial respiratory chain complex I &                      68 &                   8.361 &      8.133 &         6.7e$^{-35}$ &         6.9e$^{-31}$ \\
                                   Golgi apparatus &                    2181 &                  1630.4 &      1.338 &         9.4e$^{-35}$ &         9.6e$^{-31}$ \\
         low-density lipoprotein receptor activity &                     259 &                   105.2 &      2.461 &         9.8e$^{-35}$ &           1e$^{-30}$ \\
               flavin adenine dinucleotide binding &                     303 &                   133.4 &      2.271 &         1.5e$^{-34}$ &         1.6e$^{-30}$ \\
                   glucose transmembrane transport &                     128 &                    32.7 &      3.914 &         2.3e$^{-34}$ &         2.3e$^{-30}$ \\
                         inorganic anion transport &                     128 &                    32.8 &      3.901 &           3e$^{-34}$ &         3.1e$^{-30}$ \\
                       scavenger receptor activity &                     297 &                   130.5 &      2.276 &         4.8e$^{-34}$ &         4.9e$^{-30}$ \\
               positive regulation of phagocytosis &                     166 &                    52.5 &      3.165 &         7.3e$^{-34}$ &         7.5e$^{-30}$ \\
                                      cell surface &                    1161 &                   785.0 &      1.479 &         1.1e$^{-33}$ &         1.1e$^{-29}$ \\
           post-translational protein modification &                     748 &                   458.0 &      1.633 &         1.8e$^{-33}$ &         1.8e$^{-29}$ \\
                                     cell adhesion &                    1646 &                  1187.1 &      1.387 &         1.9e$^{-33}$ &           2e$^{-29}$ \\
                serine-type endopeptidase activity &                     455 &                   240.3 &      1.893 &         3.3e$^{-33}$ &         3.4e$^{-29}$ \\
                   apoptotic mitochondrial changes &                      66 &                   8.434 &      7.826 &         4.3e$^{-33}$ &         4.5e$^{-29}$ \\
                                              axon &                     626 &                   366.7 &      1.707 &         5.5e$^{-33}$ &         5.7e$^{-29}$ \\
                                          endosome &                    1287 &                   892.3 &      1.442 &         7.2e$^{-33}$ &         7.4e$^{-29}$ \\
      serine-type endopeptidase inhibitor activity &                     263 &                   111.4 &      2.360 &         1.3e$^{-32}$ &         1.4e$^{-28}$ \\
                           virus receptor activity &                     266 &                   113.5 &      2.344 &         1.6e$^{-32}$ &         1.6e$^{-28}$ \\
                                   myosin filament &                      94 &                    19.0 &      4.947 &         1.8e$^{-32}$ &         1.8e$^{-28}$ \\
                  extracellular matrix disassembly &                     337 &                   160.3 &      2.102 &         2.3e$^{-32}$ &         2.3e$^{-28}$ \\
          calcium-independent cell-matrix adhesion &                      79 &                    13.3 &      5.956 &         3.1e$^{-32}$ &         3.1e$^{-28}$ \\
                                 endosome membrane &                     505 &                   279.9 &      1.804 &         5.1e$^{-32}$ &         5.2e$^{-28}$ \\
                  mitochondrial electron transport &                      62 &                   7.671 &      8.082 &         7.7e$^{-32}$ &         7.8e$^{-28}$ \\
                                 respiratory chain &                      62 &                   7.671 &      8.082 &         7.7e$^{-32}$ &         7.8e$^{-28}$ \\
          NADH dehydrogenase (ubiquinone) activity &                      62 &                   7.671 &      8.082 &         7.7e$^{-32}$ &         7.8e$^{-28}$ \\
                                     wound healing &                     363 &                   179.4 &      2.024 &         8.4e$^{-32}$ &         8.6e$^{-28}$ \\
                      peptidase inhibitor activity &                     284 &                   126.4 &      2.247 &         8.4e$^{-32}$ &         8.6e$^{-28}$ \\
                        electron transfer activity &                     139 &                    40.5 &      3.429 &         8.5e$^{-32}$ &         8.7e$^{-28}$ \\
              positive regulation of lipid storage &                     160 &                    51.6 &      3.099 &         8.8e$^{-32}$ &           9e$^{-28}$ \\
        low-density lipoprotein particle clearance &                     128 &                    35.1 &      3.650 &         9.7e$^{-32}$ &         9.9e$^{-28}$ \\
                             bicarbonate transport &                     176 &                    60.6 &      2.906 &         1.1e$^{-31}$ &         1.1e$^{-27}$ \\
                                      pseudopodium &                      54 &                   5.491 &      9.834 &           2e$^{-31}$ &           2e$^{-27}$ \\
 negative regulation of endoplasmic reticulum c... &                      53 &                   5.237 &       10.1 &         2.2e$^{-31}$ &         2.3e$^{-27}$ \\
 extrinsic component of external side of plasma... &                     140 &                    41.7 &      3.360 &         3.3e$^{-31}$ &         3.4e$^{-27}$ \\
                    endothelial cell proliferation &                     100 &                    22.7 &      4.412 &         7.1e$^{-31}$ &         7.2e$^{-27}$ \\
 homophilic cell adhesion via plasma membrane a... &                     502 &                   281.2 &      1.785 &         7.2e$^{-31}$ &         7.4e$^{-27}$ \\
      negative regulation of programmed cell death &                     100 &                    22.9 &      4.370 &         1.4e$^{-30}$ &         1.4e$^{-26}$ \\
                         specific granule membrane &                     263 &                   115.3 &      2.282 &         1.6e$^{-30}$ &         1.6e$^{-26}$ \\
                    sphingolipid metabolic process &                     152 &                    49.0 &      3.103 &         2.4e$^{-30}$ &         2.5e$^{-26}$ \\
                              extracellular matrix &                     989 &                   662.9 &      1.492 &         2.9e$^{-30}$ &           3e$^{-26}$ \\
 mitochondrial respiratory chain complex I asse... &                     100 &                    23.2 &      4.308 &         3.8e$^{-30}$ &         3.9e$^{-26}$ \\
                                 endocytic vesicle &                     284 &                   130.1 &      2.182 &           6e$^{-30}$ &         6.1e$^{-26}$ \\
                        viral entry into host cell &                     283 &                   129.7 &      2.183 &         7.4e$^{-30}$ &         7.6e$^{-26}$ \\
         negative regulation of peptidase activity &                     289 &                   134.0 &      2.157 &         1.1e$^{-29}$ &         1.1e$^{-25}$ \\
                             brush border membrane &                     308 &                   146.8 &      2.098 &         1.2e$^{-29}$ &         1.2e$^{-25}$ \\
                         interaction with symbiont &                      86 &                    17.6 &      4.900 &         1.3e$^{-29}$ &         1.4e$^{-25}$ \\
                                   ankyrin binding &                      99 &                    23.3 &      4.251 &         1.8e$^{-29}$ &         1.9e$^{-25}$ \\
                        lipid transporter activity &                     120 &                    33.3 &      3.600 &         2.2e$^{-29}$ &         2.2e$^{-25}$ \\
 negative regulation of protein localization to... &                      47 &                   4.256 &       11.0 &         2.4e$^{-29}$ &         2.4e$^{-25}$ \\
                                      NADP binding &                     171 &                    60.9 &      2.809 &         2.5e$^{-29}$ &         2.6e$^{-25}$ \\
                            sarcomere organization &                     131 &                    39.1 &      3.347 &         3.5e$^{-29}$ &         3.6e$^{-25}$ \\
                       sensory perception of sound &                     457 &                   253.4 &      1.804 &         3.7e$^{-29}$ &         3.8e$^{-25}$ \\
                            apolipoprotein binding &                     105 &                    26.5 &      3.960 &         6.8e$^{-29}$ &           7e$^{-25}$ \\
                     ceramide biosynthetic process &                     108 &                    28.1 &      3.837 &         1.2e$^{-28}$ &         1.2e$^{-24}$ \\
   ionotropic glutamate receptor signaling pathway &                      31 &                   1.128 &       27.5 &         1.3e$^{-28}$ &         1.3e$^{-24}$ \\
                     reverse cholesterol transport &                      80 &                    15.8 &      5.072 &         1.6e$^{-28}$ &         1.6e$^{-24}$ \\
                      coenzyme A metabolic process &                      39 &                   2.620 &       14.9 &         2.2e$^{-28}$ &         2.3e$^{-24}$ \\
                              extracellular region &                    3901 &                  3197.3 &      1.220 &         2.7e$^{-28}$ &         2.8e$^{-24}$ \\
 ATP hydrolysis coupled cation transmembrane tr... &                     103 &                    26.1 &      3.944 &           3e$^{-28}$ &         3.1e$^{-24}$ \\
                                  response to drug &                     481 &                   274.3 &      1.754 &           4e$^{-28}$ &         4.1e$^{-24}$ \\
                     cholesterol catabolic process &                      60 &                   8.581 &      6.992 &           5e$^{-28}$ &         5.1e$^{-24}$ \\
 positive regulation of caveolin-mediated endoc... &                      26 &                   0.546 &       47.6 &         5.9e$^{-28}$ &           6e$^{-24}$ \\
                              amyloid-beta binding &                     197 &                    78.3 &      2.515 &         6.1e$^{-28}$ &         6.2e$^{-24}$ \\
                                  cadherin binding &                     496 &                   286.8 &      1.729 &           1e$^{-27}$ &           1e$^{-23}$ \\
                                      stereocilium &                     193 &                    76.5 &      2.523 &         1.4e$^{-27}$ &         1.5e$^{-23}$ \\
                             potassium ion binding &                      52 &                   6.256 &      8.313 &         1.8e$^{-27}$ &         1.9e$^{-23}$ \\
                            innate immune response &                     908 &                   612.5 &      1.483 &         3.1e$^{-27}$ &         3.2e$^{-23}$ \\
                 extracellular matrix organization &                     858 &                   572.2 &      1.499 &         3.4e$^{-27}$ &         3.5e$^{-23}$ \\
                              chylomicron assembly &                      81 &                    17.2 &      4.722 &         4.7e$^{-27}$ &         4.9e$^{-23}$ \\
                             cholesterol transport &                     141 &                    47.1 &      2.995 &         6.5e$^{-27}$ &         6.6e$^{-23}$ \\
                                   lipid transport &                     493 &                   287.3 &      1.716 &         6.5e$^{-27}$ &         6.6e$^{-23}$ \\
                      peptidase activator activity &                     103 &                    27.3 &      3.770 &         7.1e$^{-27}$ &         7.2e$^{-23}$ \\
 positive regulation of substrate-dependent cel... &                      67 &                    11.7 &      5.723 &         9.4e$^{-27}$ &         9.7e$^{-23}$ \\
 negative regulation of transforming growth fac... &                      67 &                    11.7 &      5.723 &         9.4e$^{-27}$ &         9.7e$^{-23}$ \\
 interaction with other organism via secreted s... &                      67 &                    11.7 &      5.723 &         9.4e$^{-27}$ &         9.7e$^{-23}$ \\
                voltage-gated ion channel activity &                     258 &                   119.6 &      2.157 &         9.9e$^{-27}$ &           1e$^{-22}$ \\
                            late endosome membrane &                     207 &                    86.8 &      2.385 &         1.3e$^{-26}$ &         1.3e$^{-22}$ \\
                                phagocytic vesicle &                     166 &                    61.9 &      2.681 &         1.6e$^{-26}$ &         1.6e$^{-22}$ \\
                  cell-substrate junction assembly &                      83 &                    18.6 &      4.460 &         3.3e$^{-26}$ &         3.3e$^{-22}$ \\
                        epoxide hydrolase activity &                      61 &                   9.854 &      6.190 &         4.7e$^{-26}$ &         4.9e$^{-22}$ \\
                          electron transport chain &                     152 &                    54.5 &      2.788 &         5.6e$^{-26}$ &         5.7e$^{-22}$ \\
          cellular response to amino acid stimulus &                     155 &                    56.4 &      2.748 &         7.2e$^{-26}$ &         7.3e$^{-22}$ \\
                            carbohydrate transport &                     131 &                    42.9 &      3.052 &         8.1e$^{-26}$ &         8.3e$^{-22}$ \\
 regulation of cytosolic calcium ion concentration &                     146 &                    51.3 &      2.844 &         8.6e$^{-26}$ &         8.8e$^{-22}$ \\
              potassium channel inhibitor activity &                      26 &                   0.764 &       34.0 &         9.4e$^{-26}$ &         9.7e$^{-22}$ \\
                    triglyceride catabolic process &                      81 &                    18.1 &      4.475 &         1.1e$^{-25}$ &         1.1e$^{-21}$ \\
        glucose transmembrane transporter activity &                      86 &                    20.4 &      4.218 &         1.3e$^{-25}$ &         1.3e$^{-21}$ \\
                                muscle contraction &                     300 &                   150.8 &      1.989 &         1.4e$^{-25}$ &         1.4e$^{-21}$ \\
                                     lipid binding &                     594 &                   369.8 &      1.606 &         1.6e$^{-25}$ &         1.6e$^{-21}$ \\
                      hyaluronan metabolic process &                      89 &                    21.9 &      4.068 &         1.7e$^{-25}$ &         1.8e$^{-21}$ \\
         high-density lipoprotein particle binding &                      83 &                    19.2 &      4.317 &         2.2e$^{-25}$ &         2.3e$^{-21}$ \\
                  regulation of cardiac conduction &                     158 &                    58.9 &      2.684 &         2.3e$^{-25}$ &         2.3e$^{-21}$ \\
                    triglyceride metabolic process &                     130 &                    43.0 &      3.026 &         2.5e$^{-25}$ &         2.5e$^{-21}$ \\
                      lipopolysaccharide transport &                      39 &                   3.347 &       11.7 &         2.6e$^{-25}$ &         2.7e$^{-21}$ \\
 regulation of phosphatidylcholine catabolic pr... &                      39 &                   3.347 &       11.7 &         2.6e$^{-25}$ &         2.7e$^{-21}$ \\
                               response to ethanol &                     186 &                    76.0 &      2.447 &           3e$^{-25}$ &         3.1e$^{-21}$ \\
      positive regulation of ERK1 and ERK2 cascade &                     407 &                   228.7 &      1.780 &         3.3e$^{-25}$ &         3.3e$^{-21}$ \\
                   vitamin transmembrane transport &                      86 &                    20.7 &      4.152 &         3.3e$^{-25}$ &         3.4e$^{-21}$ \\
                                           caveola &                     221 &                    98.3 &      2.247 &         3.3e$^{-25}$ &         3.4e$^{-21}$ \\
                termination of signal transduction &                      43 &                   4.475 &      9.609 &         4.9e$^{-25}$ &           5e$^{-21}$ \\
 positive regulation of CDP-diacylglycerol-seri... &                      47 &                   5.638 &      8.336 &         5.1e$^{-25}$ &         5.2e$^{-21}$ \\
 positive regulation of serine C-palmitoyltrans... &                      47 &                   5.638 &      8.336 &         5.1e$^{-25}$ &         5.2e$^{-21}$ \\
      peripheral nervous system myelin maintenance &                      37 &                   2.947 &       12.6 &         5.5e$^{-25}$ &         5.6e$^{-21}$ \\
                        osteoblast differentiation &                     259 &                   124.2 &      2.085 &         6.6e$^{-25}$ &         6.7e$^{-21}$ \\
 extracellularly glutamate-gated ion channel ac... &                      23 &                   0.510 &       45.1 &         1.4e$^{-24}$ &         1.4e$^{-20}$ \\
            ionotropic glutamate receptor activity &                      23 &                   0.510 &       45.1 &         1.4e$^{-24}$ &         1.4e$^{-20}$ \\
                              antioxidant activity &                      73 &                    15.5 &      4.725 &         1.4e$^{-24}$ &         1.5e$^{-20}$ \\
                               metal ion transport &                     181 &                    74.1 &      2.442 &         1.6e$^{-24}$ &         1.6e$^{-20}$ \\
 positive regulation of neutrophil apoptotic pr... &                      46 &                   5.529 &      8.319 &         1.7e$^{-24}$ &         1.7e$^{-20}$ \\
       potassium ion import across plasma membrane &                      32 &                   1.965 &       16.3 &         1.8e$^{-24}$ &         1.8e$^{-20}$ \\
                                   node of Ranvier &                      89 &                    22.7 &      3.912 &         1.9e$^{-24}$ &           2e$^{-20}$ \\
                   cellular sodium ion homeostasis &                      72 &                    15.2 &      4.749 &         2.3e$^{-24}$ &         2.3e$^{-20}$ \\
                             lipoprotein transport &                     255 &                   122.7 &      2.078 &         2.3e$^{-24}$ &         2.4e$^{-20}$ \\
    positive regulation of protein phosphorylation &                     351 &                   190.3 &      1.844 &         2.4e$^{-24}$ &         2.5e$^{-20}$ \\
 positive regulation of neuron projection devel... &                     223 &                   101.4 &      2.199 &         2.5e$^{-24}$ &         2.6e$^{-20}$ \\
                                neuronal cell body &                     612 &                   389.0 &      1.573 &         2.7e$^{-24}$ &         2.8e$^{-20}$ \\
                             intestinal absorption &                      93 &                    24.9 &      3.742 &         3.1e$^{-24}$ &         3.2e$^{-20}$ \\
      G-protein coupled receptor signaling pathway &                    1288 &                   946.5 &      1.361 &         3.2e$^{-24}$ &         3.3e$^{-20}$ \\
                      semaphorin receptor activity &                     101 &                    28.9 &      3.492 &         3.9e$^{-24}$ &           4e$^{-20}$ \\
                   endodermal cell differentiation &                     157 &                    60.6 &      2.590 &         8.4e$^{-24}$ &         8.6e$^{-20}$ \\
                           collagen type VI trimer &                      91 &                    24.3 &      3.749 &         8.5e$^{-24}$ &         8.7e$^{-20}$ \\
                               cholesterol binding &                     148 &                    55.3 &      2.677 &         8.8e$^{-24}$ &           9e$^{-20}$ \\
                              ion channel activity &                     316 &                   167.0 &      1.892 &         1.1e$^{-23}$ &         1.2e$^{-19}$ \\
             regulation of protein phosphorylation &                     182 &                    76.3 &      2.386 &         1.2e$^{-23}$ &         1.2e$^{-19}$ \\
 positive regulation of mitochondrial calcium i... &                      44 &                   5.239 &      8.399 &         1.2e$^{-23}$ &         1.3e$^{-19}$ \\
                                   peptide binding &                     180 &                    75.1 &      2.396 &         1.4e$^{-23}$ &         1.4e$^{-19}$ \\
                 bile acid and bile salt transport &                     121 &                    40.2 &      3.012 &         1.5e$^{-23}$ &         1.5e$^{-19}$ \\
             regulation of lipid metabolic process &                     217 &                    99.3 &      2.185 &         2.1e$^{-23}$ &         2.1e$^{-19}$ \\
    striated muscle myosin thick filament assembly &                      81 &                    19.9 &      4.067 &         2.4e$^{-23}$ &         2.5e$^{-19}$ \\
 structural molecule activity conferring elasti... &                      81 &                    19.9 &      4.067 &         2.4e$^{-23}$ &         2.5e$^{-19}$ \\
                             muscle myosin complex &                      81 &                    19.9 &      4.067 &         2.4e$^{-23}$ &         2.5e$^{-19}$ \\
 establishment or maintenance of transmembrane ... &                      44 &                   5.348 &      8.228 &         2.4e$^{-23}$ &         2.5e$^{-19}$ \\
                                            Z disc &                     298 &                   155.1 &      1.921 &         2.6e$^{-23}$ &         2.7e$^{-19}$ \\
                               signal transduction &                    2933 &                  2395.1 &      1.225 &         2.9e$^{-23}$ &           3e$^{-19}$ \\
                              response to wounding &                     131 &                    46.2 &      2.834 &         3.3e$^{-23}$ &         3.4e$^{-19}$ \\
                              potassium ion import &                      38 &                   3.711 &       10.2 &         4.2e$^{-23}$ &         4.3e$^{-19}$ \\
               response to organic cyclic compound &                     213 &                    97.3 &      2.189 &         4.3e$^{-23}$ &         4.4e$^{-19}$ \\
              toll-like receptor signaling pathway &                     195 &                    85.7 &      2.277 &         4.8e$^{-23}$ &           5e$^{-19}$ \\
                    carbohydrate metabolic process &                     412 &                   239.5 &      1.720 &         5.1e$^{-23}$ &         5.2e$^{-19}$ \\
                                        peroxisome &                     346 &                   190.5 &      1.816 &         5.1e$^{-23}$ &         5.2e$^{-19}$ \\
       L-serine transmembrane transporter activity &                      89 &                    24.0 &      3.705 &         5.2e$^{-23}$ &         5.4e$^{-19}$ \\
                                L-serine transport &                      89 &                    24.0 &      3.705 &         5.2e$^{-23}$ &         5.4e$^{-19}$ \\
   calcium activated phosphatidylserine scrambling &                      64 &                    12.7 &      5.029 &         5.3e$^{-23}$ &         5.5e$^{-19}$ \\
         calcium activated phospholipid scrambling &                      64 &                    12.7 &      5.029 &         5.3e$^{-23}$ &         5.5e$^{-19}$ \\
   calcium activated galactosylceramide scrambling &                      64 &                    12.7 &      5.029 &         5.3e$^{-23}$ &         5.5e$^{-19}$ \\
  calcium activated phosphatidylcholine scrambling &                      64 &                    12.7 &      5.029 &         5.3e$^{-23}$ &         5.5e$^{-19}$ \\
   methotrexate transmembrane transporter activity &                      35 &                   2.984 &       11.7 &         5.9e$^{-23}$ &           6e$^{-19}$ \\
                                folic acid binding &                      35 &                   2.984 &       11.7 &         5.9e$^{-23}$ &           6e$^{-19}$ \\
                            methotrexate transport &                      35 &                   2.984 &       11.7 &         5.9e$^{-23}$ &           6e$^{-19}$ \\
            reduced folate transmembrane transport &                      35 &                   2.984 &       11.7 &         5.9e$^{-23}$ &           6e$^{-19}$ \\
     folic acid transmembrane transporter activity &                      35 &                   2.984 &       11.7 &         5.9e$^{-23}$ &           6e$^{-19}$ \\
                   reduced folate carrier activity &                      35 &                   2.984 &       11.7 &         5.9e$^{-23}$ &           6e$^{-19}$ \\
                              folic acid transport &                      35 &                   2.984 &       11.7 &         5.9e$^{-23}$ &           6e$^{-19}$ \\
 positive regulation of nitric-oxide synthase a... &                      86 &                    22.6 &      3.798 &         6.4e$^{-23}$ &         6.5e$^{-19}$ \\
               regulation of complement activation &                     254 &                   125.4 &      2.026 &         6.6e$^{-23}$ &         6.8e$^{-19}$ \\
 negative regulation of intrinsic apoptotic sig... &                      32 &                   2.329 &       13.7 &         9.4e$^{-23}$ &         9.6e$^{-19}$ \\
                    cilium-dependent cell motility &                      76 &                    18.1 &      4.190 &         1.1e$^{-22}$ &         1.1e$^{-18}$ \\
                  cholesterol biosynthetic process &                     154 &                    60.6 &      2.540 &         1.2e$^{-22}$ &         1.3e$^{-18}$ \\
                             neutrophil chemotaxis &                     132 &                    47.8 &      2.764 &         1.7e$^{-22}$ &         1.7e$^{-18}$ \\
                                protein lipidation &                      60 &                    11.4 &      5.254 &         1.7e$^{-22}$ &         1.7e$^{-18}$ \\
                    neuron projection regeneration &                      73 &                    17.0 &      4.300 &         1.9e$^{-22}$ &           2e$^{-18}$ \\
                   linoleic acid metabolic process &                      91 &                    25.5 &      3.562 &         1.9e$^{-22}$ &           2e$^{-18}$ \\
                        phosphatidylserine binding &                     102 &                    31.2 &      3.268 &           2e$^{-22}$ &           2e$^{-18}$ \\
                            platelet degranulation &                     444 &                   265.9 &      1.670 &         2.2e$^{-22}$ &         2.2e$^{-18}$ \\
 cellular response to epidermal growth factor s... &                     108 &                    34.6 &      3.123 &         2.8e$^{-22}$ &         2.9e$^{-18}$ \\
                                       gliogenesis &                      31 &                   2.220 &       14.0 &           3e$^{-22}$ &         3.1e$^{-18}$ \\
                            protein polymerization &                      76 &                    18.5 &      4.107 &         3.1e$^{-22}$ &         3.2e$^{-18}$ \\
                                   dendritic spine &                     218 &                   102.6 &      2.125 &         3.8e$^{-22}$ &         3.8e$^{-18}$ \\
             regulation of membrane depolarization &                      21 &                   0.510 &       41.2 &         4.2e$^{-22}$ &         4.3e$^{-18}$ \\
 negative regulation of sodium ion transmembran... &                      21 &                   0.510 &       41.2 &         4.2e$^{-22}$ &         4.3e$^{-18}$ \\
                 sodium channel inhibitor activity &                      21 &                   0.510 &       41.2 &         4.2e$^{-22}$ &         4.3e$^{-18}$ \\
 negative regulation of sodium ion transmembran... &                      21 &                   0.510 &       41.2 &         4.2e$^{-22}$ &         4.3e$^{-18}$ \\
 regulation of long-term neuronal synaptic plas... &                      42 &                   5.203 &      8.073 &         4.3e$^{-22}$ &         4.4e$^{-18}$ \\
                                    endosome lumen &                     127 &                    45.5 &      2.791 &         4.9e$^{-22}$ &           5e$^{-18}$ \\
          sodium ion export across plasma membrane &                      45 &                   6.185 &      7.276 &         5.1e$^{-22}$ &         5.2e$^{-18}$ \\
                  regulation of membrane potential &                     181 &                    78.6 &      2.303 &         5.3e$^{-22}$ &         5.4e$^{-18}$ \\
                             peptide cross-linking &                     154 &                    61.7 &      2.497 &         5.6e$^{-22}$ &         5.7e$^{-18}$ \\
                   cellular oxidant detoxification &                     110 &                    36.0 &      3.052 &         5.7e$^{-22}$ &         5.9e$^{-18}$ \\
                            monooxygenase activity &                     225 &                   108.0 &      2.082 &         7.9e$^{-22}$ &         8.1e$^{-18}$ \\
 low-density lipoprotein particle receptor binding &                     115 &                    39.0 &      2.948 &         8.5e$^{-22}$ &         8.7e$^{-18}$ \\
                                 glucose transport &                      43 &                   5.639 &      7.625 &         8.9e$^{-22}$ &         9.2e$^{-18}$ \\
   hydrogen ion transmembrane transporter activity &                      85 &                    23.3 &      3.654 &           1e$^{-21}$ &         1.1e$^{-17}$ \\
                                      vasodilation &                     114 &                    38.7 &      2.949 &         1.2e$^{-21}$ &         1.2e$^{-17}$ \\
 positive regulation of heterotypic cell-cell a... &                      96 &                    29.0 &      3.310 &         1.5e$^{-21}$ &         1.5e$^{-17}$ \\
                    cell adhesion molecule binding &                     150 &                    59.9 &      2.504 &         1.5e$^{-21}$ &         1.5e$^{-17}$ \\
                           response to calcium ion &                     150 &                    59.9 &      2.502 &         1.5e$^{-21}$ &         1.6e$^{-17}$ \\
                            actin filament binding &                     423 &                   253.1 &      1.671 &         1.7e$^{-21}$ &         1.8e$^{-17}$ \\
            ATP synthesis coupled proton transport &                      57 &                    10.8 &      5.259 &         1.8e$^{-21}$ &         1.8e$^{-17}$ \\
                       single-stranded RNA binding &                      97 &                    29.7 &      3.271 &         1.9e$^{-21}$ &           2e$^{-17}$ \\
                                       proteolysis &                    1361 &                  1029.9 &      1.322 &         2.4e$^{-21}$ &         2.5e$^{-17}$ \\
                      smooth endoplasmic reticulum &                      75 &                    18.8 &      3.990 &         2.6e$^{-21}$ &         2.6e$^{-17}$ \\
                                    oxygen binding &                     101 &                    32.0 &      3.159 &         2.9e$^{-21}$ &         2.9e$^{-17}$ \\
                      long-chain fatty acid import &                      52 &                   9.021 &      5.765 &         2.9e$^{-21}$ &           3e$^{-17}$ \\
 positive regulation of protein processing in p... &                      34 &                   3.202 &       10.6 &         3.1e$^{-21}$ &         3.1e$^{-17}$ \\
                 proton-transporting V-type ATPase &                      51 &                   8.694 &      5.866 &         3.6e$^{-21}$ &         3.7e$^{-17}$ \\
                 taurine:sodium symporter activity &                      24 &                   1.056 &       22.7 &         3.6e$^{-21}$ &         3.7e$^{-17}$ \\
        taurine transmembrane transporter activity &                      24 &                   1.056 &       22.7 &         3.6e$^{-21}$ &         3.7e$^{-17}$ \\
                                 taurine transport &                      24 &                   1.056 &       22.7 &         3.6e$^{-21}$ &         3.7e$^{-17}$ \\
                                skin morphogenesis &                      66 &                    14.8 &      4.449 &         3.8e$^{-21}$ &         3.9e$^{-17}$ \\
                     lipoprotein metabolic process &                      75 &                    19.0 &      3.952 &         4.3e$^{-21}$ &         4.4e$^{-17}$ \\
                            collagen type I trimer &                      36 &                   3.821 &      9.422 &         5.4e$^{-21}$ &         5.6e$^{-17}$ \\
                branchiomotor neuron axon guidance &                      57 &                    11.2 &      5.088 &           7e$^{-21}$ &         7.2e$^{-17}$ \\
                arachidonic acid metabolic process &                     106 &                    35.2 &      3.011 &         7.8e$^{-21}$ &         7.9e$^{-17}$ \\
                      ficolin-1-rich granule lumen &                     176 &                    77.6 &      2.267 &         8.3e$^{-21}$ &         8.5e$^{-17}$ \\
                                       NAD binding &                      97 &                    30.4 &      3.193 &         8.7e$^{-21}$ &         8.9e$^{-17}$ \\
        vacuolar proton-transporting V-type ATPase &                      50 &                   8.585 &      5.824 &         1.1e$^{-20}$ &         1.2e$^{-16}$ \\
                                   ligase activity &                     418 &                   252.3 &      1.657 &         1.1e$^{-20}$ &         1.2e$^{-16}$ \\
                    hepoxilin biosynthetic process &                      74 &                    18.9 &      3.922 &         1.1e$^{-20}$ &         1.2e$^{-16}$ \\
                                     viral process &                     701 &                   477.6 &      1.468 &         1.2e$^{-20}$ &         1.2e$^{-16}$ \\
                            vacuolar acidification &                      51 &                   8.985 &      5.676 &         1.2e$^{-20}$ &         1.3e$^{-16}$ \\
                      lipoprotein particle binding &                      58 &                    11.8 &      4.922 &         1.3e$^{-20}$ &         1.3e$^{-16}$ \\
         protein disulfide oxidoreductase activity &                     135 &                    52.4 &      2.576 &         1.5e$^{-20}$ &         1.6e$^{-16}$ \\
                      intestinal hexose absorption &                      46 &                   7.203 &      6.386 &         1.6e$^{-20}$ &         1.7e$^{-16}$ \\
              calcium-transporting ATPase activity &                      83 &                    23.6 &      3.524 &         2.3e$^{-20}$ &         2.4e$^{-16}$ \\
            voltage-gated calcium channel activity &                     133 &                    51.5 &      2.582 &         2.4e$^{-20}$ &         2.5e$^{-16}$ \\
       sodium:potassium-exchanging ATPase activity &                      33 &                   3.203 &       10.3 &         2.4e$^{-20}$ &         2.5e$^{-16}$ \\
                cellular potassium ion homeostasis &                      33 &                   3.203 &       10.3 &         2.4e$^{-20}$ &         2.5e$^{-16}$ \\
        sodium:potassium-exchanging ATPase complex &                      39 &                   4.949 &      7.881 &         2.5e$^{-20}$ &         2.6e$^{-16}$ \\
  fatty acid beta-oxidation using acyl-CoA oxidase &                      95 &                    29.8 &      3.184 &         2.5e$^{-20}$ &         2.6e$^{-16}$ \\
       branched-chain amino acid catabolic process &                      76 &                    20.2 &      3.767 &         2.9e$^{-20}$ &         2.9e$^{-16}$ \\
                                  outer dynein arm &                      79 &                    21.7 &      3.640 &         3.3e$^{-20}$ &         3.4e$^{-16}$ \\
                           oxidoreductase activity &                      80 &                    22.2 &      3.602 &         3.4e$^{-20}$ &         3.5e$^{-16}$ \\
                       sterol biosynthetic process &                     125 &                    47.0 &      2.661 &         3.5e$^{-20}$ &         3.6e$^{-16}$ \\
                      regulation of blood pressure &                     200 &                    94.8 &      2.109 &         3.6e$^{-20}$ &         3.7e$^{-16}$ \\
                 excitatory postsynaptic potential &                     109 &                    37.8 &      2.887 &         3.8e$^{-20}$ &         3.9e$^{-16}$ \\
               negative regulation of angiogenesis &                     253 &                   131.9 &      1.918 &         5.3e$^{-20}$ &         5.4e$^{-16}$ \\
             positive regulation of axon extension &                     109 &                    38.2 &      2.854 &         8.1e$^{-20}$ &         8.3e$^{-16}$ \\
                                  integrin binding &                     399 &                   240.9 &      1.656 &         8.3e$^{-20}$ &         8.5e$^{-16}$ \\
                      folic acid metabolic process &                      74 &                    19.6 &      3.769 &         8.5e$^{-20}$ &         8.7e$^{-16}$ \\
                            dendrite morphogenesis &                     106 &                    36.7 &      2.891 &         1.1e$^{-19}$ &         1.1e$^{-15}$ \\
                disordered domain specific binding &                      93 &                    29.5 &      3.151 &         1.2e$^{-19}$ &         1.2e$^{-15}$ \\
                                          dendrite &                     685 &                   469.7 &      1.458 &         1.2e$^{-19}$ &         1.2e$^{-15}$ \\
                     recognition of apoptotic cell &                      46 &                   7.640 &      6.021 &         1.2e$^{-19}$ &         1.2e$^{-15}$ \\
                                 aorta development &                     145 &                    60.1 &      2.411 &         1.4e$^{-19}$ &         1.5e$^{-15}$ \\
                            actin filament capping &                      76 &                    20.9 &      3.642 &         1.6e$^{-19}$ &         1.7e$^{-15}$ \\
                         fatty acid beta-oxidation &                     180 &                    82.8 &      2.173 &         1.6e$^{-19}$ &         1.7e$^{-15}$ \\
                eye photoreceptor cell development &                      78 &                    21.9 &      3.564 &         1.7e$^{-19}$ &         1.7e$^{-15}$ \\
                      xenobiotic metabolic process &                     158 &                    68.6 &      2.302 &           2e$^{-19}$ &           2e$^{-15}$ \\
                        aldehyde catabolic process &                      44 &                   7.022 &      6.266 &           2e$^{-19}$ &           2e$^{-15}$ \\
                   cardiac muscle cell development &                      37 &                   4.694 &      7.882 &         2.3e$^{-19}$ &         2.4e$^{-15}$ \\
 intracellular calcium activated chloride chann... &                     115 &                    42.3 &      2.717 &         2.5e$^{-19}$ &         2.6e$^{-15}$ \\
         central nervous system myelin maintenance &                      27 &                   2.002 &       13.5 &         2.8e$^{-19}$ &         2.9e$^{-15}$ \\
             fatty acid alpha-hydroxylase activity &                      27 &                   2.002 &       13.5 &         2.8e$^{-19}$ &         2.9e$^{-15}$ \\
              sebaceous gland cell differentiation &                      27 &                   2.002 &       13.5 &         2.8e$^{-19}$ &         2.9e$^{-15}$ \\
                                lipid modification &                      27 &                   2.002 &       13.5 &         2.8e$^{-19}$ &         2.9e$^{-15}$ \\
                                 blood coagulation &                      78 &                    22.1 &      3.529 &         2.9e$^{-19}$ &         2.9e$^{-15}$ \\
          positive regulation of peptide secretion &                      29 &                   2.511 &       11.5 &         3.9e$^{-19}$ &           4e$^{-15}$ \\
                                 cobalamin binding &                     120 &                    45.6 &      2.634 &         3.9e$^{-19}$ &           4e$^{-15}$ \\
 regulation of axon extension involved in axon ... &                      50 &                   9.458 &      5.286 &           4e$^{-19}$ &         4.1e$^{-15}$ \\
                       striated muscle contraction &                     108 &                    38.6 &      2.799 &         4.3e$^{-19}$ &         4.4e$^{-15}$ \\
        phospholipid-translocating ATPase activity &                     140 &                    57.9 &      2.420 &         4.4e$^{-19}$ &         4.6e$^{-15}$ \\
                        phospholipid translocation &                     140 &                    57.9 &      2.420 &         4.4e$^{-19}$ &         4.6e$^{-15}$ \\
                     sphinganine metabolic process &                      21 &                   0.874 &       24.0 &         4.8e$^{-19}$ &         4.9e$^{-15}$ \\
          sphingolipid delta-4 desaturase activity &                      21 &                   0.874 &       24.0 &         4.8e$^{-19}$ &         4.9e$^{-15}$ \\
                  sphingosine hydroxylase activity &                      21 &                   0.874 &       24.0 &         4.8e$^{-19}$ &         4.9e$^{-15}$ \\
               glycosaminoglycan metabolic process &                     166 &                    74.6 &      2.225 &         5.1e$^{-19}$ &         5.2e$^{-15}$ \\
            alpha-linolenic acid metabolic process &                      61 &                    14.3 &      4.257 &         7.6e$^{-19}$ &         7.8e$^{-15}$ \\
                            transketolase activity &                      21 &                   0.910 &       23.1 &         8.6e$^{-19}$ &         8.8e$^{-15}$ \\
                     xylulose biosynthetic process &                      21 &                   0.910 &       23.1 &         8.6e$^{-19}$ &         8.8e$^{-15}$ \\
   glyceraldehyde-3-phosphate biosynthetic process &                      21 &                   0.910 &       23.1 &         8.6e$^{-19}$ &         8.8e$^{-15}$ \\
                           pentose-phosphate shunt &                      21 &                   0.910 &       23.1 &         8.6e$^{-19}$ &         8.8e$^{-15}$ \\
 vacuolar proton-transporting V-type ATPase com... &                      47 &                   8.477 &      5.545 &         8.7e$^{-19}$ &         8.9e$^{-15}$ \\
            transition between fast and slow fiber &                      26 &                   1.893 &       13.7 &           9e$^{-19}$ &         9.2e$^{-15}$ \\
                    neuron projection arborization &                     107 &                    38.5 &      2.781 &         9.6e$^{-19}$ &         9.8e$^{-15}$ \\
                               response to hormone &                     152 &                    66.2 &      2.297 &         1.1e$^{-18}$ &         1.1e$^{-14}$ \\
               positive regulation of phagocytosis &                      61 &                    14.5 &      4.214 &         1.2e$^{-18}$ &         1.2e$^{-14}$ \\
                        regulation of phagocytosis &                      52 &                    10.6 &      4.912 &         1.3e$^{-18}$ &         1.3e$^{-14}$ \\
                                vagina development &                     135 &                    55.5 &      2.431 &         1.3e$^{-18}$ &         1.3e$^{-14}$ \\
         calcium activated cation channel activity &                      66 &                    16.8 &      3.920 &         1.3e$^{-18}$ &         1.3e$^{-14}$ \\
 inner ear receptor cell stereocilium organization &                     136 &                    56.2 &      2.419 &         1.4e$^{-18}$ &         1.5e$^{-14}$ \\
           aldehyde dehydrogenase NAD(P)+ activity &                      43 &                   7.095 &      6.061 &         1.5e$^{-18}$ &         1.5e$^{-14}$ \\
     3-chloroallyl aldehyde dehydrogenase activity &                      43 &                   7.095 &      6.061 &         1.5e$^{-18}$ &         1.5e$^{-14}$ \\
   ferrous iron transmembrane transporter activity &                      38 &                   5.349 &      7.104 &         1.5e$^{-18}$ &         1.5e$^{-14}$ \\
              ferrous iron transmembrane transport &                      38 &                   5.349 &      7.104 &         1.5e$^{-18}$ &         1.5e$^{-14}$ \\
              phosphatidylserine metabolic process &                      54 &                    11.5 &      4.698 &         1.6e$^{-18}$ &         1.7e$^{-14}$ \\
          folic acid import across plasma membrane &                     105 &                    37.6 &      2.789 &         1.6e$^{-18}$ &         1.7e$^{-14}$ \\
                  steroid hormone receptor binding &                     105 &                    37.6 &      2.789 &         1.6e$^{-18}$ &         1.7e$^{-14}$ \\
 positive regulation of oligodendrocyte progeni... &                     105 &                    37.6 &      2.789 &         1.6e$^{-18}$ &         1.7e$^{-14}$ \\
 positive regulation of lysosomal protein catab... &                     105 &                    37.6 &      2.789 &         1.6e$^{-18}$ &         1.7e$^{-14}$ \\
                                 receptor activity &                     564 &                   376.9 &      1.497 &         1.7e$^{-18}$ &         1.7e$^{-14}$ \\
                outflow tract septum morphogenesis &                     122 &                    47.7 &      2.556 &         1.7e$^{-18}$ &         1.8e$^{-14}$ \\
                           calcium channel complex &                      51 &                    10.3 &      4.972 &         1.8e$^{-18}$ &         1.8e$^{-14}$ \\
              sensory perception of light stimulus &                     101 &                    35.4 &      2.850 &         1.9e$^{-18}$ &         1.9e$^{-14}$ \\
                           potassium ion transport &                     202 &                   100.2 &      2.017 &           2e$^{-18}$ &         2.1e$^{-14}$ \\
                                  viral life cycle &                      40 &                   6.113 &      6.543 &         2.3e$^{-18}$ &         2.3e$^{-14}$ \\
                                 equilibrioception &                      92 &                    30.5 &      3.017 &         2.3e$^{-18}$ &         2.3e$^{-14}$ \\
 regulation of potassium ion transmembrane tran... &                      42 &                   6.840 &      6.140 &         2.4e$^{-18}$ &         2.5e$^{-14}$ \\
                        apolipoprotein A-I binding &                      40 &                   6.149 &      6.505 &         2.7e$^{-18}$ &         2.8e$^{-14}$ \\
                               platelet activation &                     255 &                   138.0 &      1.847 &         2.7e$^{-18}$ &         2.8e$^{-14}$ \\
     negative regulation of osteoclast development &                      41 &                   6.513 &      6.295 &         2.8e$^{-18}$ &         2.9e$^{-14}$ \\
                               leukocyte migration &                     322 &                   187.9 &      1.714 &         3.2e$^{-18}$ &         3.3e$^{-14}$ \\
                           phagosome acidification &                      53 &                    11.3 &      4.700 &         3.3e$^{-18}$ &         3.4e$^{-14}$ \\
                      relaxation of cardiac muscle &                      42 &                   6.950 &      6.044 &           4e$^{-18}$ &         4.1e$^{-14}$ \\
                                isomerase activity &                     194 &                    95.5 &      2.032 &         4.7e$^{-18}$ &         4.8e$^{-14}$ \\
         cytoskeletal anchoring at plasma membrane &                      54 &                    11.8 &      4.568 &         4.8e$^{-18}$ &         4.9e$^{-14}$ \\
                                     axon guidance &                     345 &                   206.1 &      1.674 &         5.4e$^{-18}$ &         5.5e$^{-14}$ \\
   membrane depolarization during action potential &                      97 &                    33.8 &      2.873 &         5.4e$^{-18}$ &         5.5e$^{-14}$ \\
                  coronary vasculature development &                     140 &                    59.8 &      2.342 &         5.6e$^{-18}$ &         5.7e$^{-14}$ \\
                             RAGE receptor binding &                      28 &                   2.584 &       10.8 &           6e$^{-18}$ &         6.1e$^{-14}$ \\
                            response to oleic acid &                      47 &                   8.986 &      5.230 &         6.5e$^{-18}$ &         6.6e$^{-14}$ \\
                         vitamin metabolic process &                     121 &                    48.1 &      2.515 &         7.1e$^{-18}$ &         7.2e$^{-14}$ \\
                                      heme binding &                     251 &                   136.4 &      1.840 &         7.4e$^{-18}$ &         7.6e$^{-14}$ \\
                    dehydroascorbic acid transport &                      35 &                   4.658 &      7.514 &         7.5e$^{-18}$ &         7.7e$^{-14}$ \\
 dehydroascorbic acid transmembrane transporter... &                      35 &                   4.658 &      7.514 &         7.5e$^{-18}$ &         7.7e$^{-14}$ \\
                                excitatory synapse &                      45 &                   8.259 &      5.449 &         8.3e$^{-18}$ &         8.5e$^{-14}$ \\
                          tricarboxylic acid cycle &                      70 &                    19.5 &      3.585 &         8.7e$^{-18}$ &         8.9e$^{-14}$ \\
                        nervous system development &                     799 &                   575.7 &      1.388 &           1e$^{-17}$ &           1e$^{-13}$ \\
                positive regulation of endocytosis &                      63 &                    16.2 &      3.893 &           1e$^{-17}$ &         1.1e$^{-13}$ \\
                                peroxisomal matrix &                     150 &                    66.8 &      2.247 &         1.1e$^{-17}$ &         1.1e$^{-13}$ \\
     double-stranded DNA-dependent ATPase activity &                      23 &                   1.493 &       15.4 &         1.3e$^{-17}$ &         1.3e$^{-13}$ \\
            regulation of interleukin-1 production &                      23 &                   1.493 &       15.4 &         1.3e$^{-17}$ &         1.3e$^{-13}$ \\
                        response to corticosteroid &                      23 &                   1.493 &       15.4 &         1.3e$^{-17}$ &         1.3e$^{-13}$ \\
                                     DNA rewinding &                      23 &                   1.493 &       15.4 &         1.3e$^{-17}$ &         1.3e$^{-13}$ \\
                            granulocyte chemotaxis &                      23 &                   1.493 &       15.4 &         1.3e$^{-17}$ &         1.3e$^{-13}$ \\
 myoblast migration involved in skeletal muscle... &                      23 &                   1.493 &       15.4 &         1.3e$^{-17}$ &         1.3e$^{-13}$ \\
        positive regulation of cholesterol storage &                      69 &                    19.2 &      3.594 &         1.3e$^{-17}$ &         1.3e$^{-13}$ \\
                         response to dexamethasone &                      67 &                    18.2 &      3.677 &         1.3e$^{-17}$ &         1.4e$^{-13}$ \\
                                       Golgi lumen &                     287 &                   163.7 &      1.753 &         1.4e$^{-17}$ &         1.4e$^{-13}$ \\
             cellular amino acid metabolic process &                     111 &                    42.6 &      2.609 &         1.5e$^{-17}$ &         1.5e$^{-13}$ \\
                                 intercalated disc &                     134 &                    56.8 &      2.360 &         1.6e$^{-17}$ &         1.6e$^{-13}$ \\
               cellular aldehyde metabolic process &                      53 &                    11.8 &      4.497 &         1.7e$^{-17}$ &         1.8e$^{-13}$ \\
                               response to hypoxia &                     291 &                   167.0 &      1.742 &         1.7e$^{-17}$ &         1.8e$^{-13}$ \\
                 negative regulation of exocytosis &                      24 &                   1.747 &       13.7 &         1.9e$^{-17}$ &           2e$^{-13}$ \\
                                sodium ion binding &                      61 &                    15.5 &      3.937 &         2.1e$^{-17}$ &         2.1e$^{-13}$ \\
 positive regulation of methylation-dependent c... &                      52 &                    11.4 &      4.552 &         2.2e$^{-17}$ &         2.3e$^{-13}$ \\
                                 tissue remodeling &                      90 &                    30.6 &      2.937 &         2.4e$^{-17}$ &         2.4e$^{-13}$ \\
                            plasma membrane repair &                      45 &                   8.550 &      5.263 &         2.6e$^{-17}$ &         2.7e$^{-13}$ \\
                         outer dynein arm assembly &                     112 &                    43.5 &      2.573 &         2.6e$^{-17}$ &         2.7e$^{-13}$ \\
                       semaphorin receptor complex &                      54 &                    12.4 &      4.366 &         2.7e$^{-17}$ &         2.8e$^{-13}$ \\
                  cholesterol transporter activity &                      75 &                    22.7 &      3.311 &         3.2e$^{-17}$ &         3.2e$^{-13}$ \\
              respiratory electron transport chain &                      47 &                   9.423 &      4.988 &         3.3e$^{-17}$ &         3.4e$^{-13}$ \\
                             transferrin transport &                      94 &                    33.1 &      2.839 &         3.4e$^{-17}$ &         3.5e$^{-13}$ \\
                              axon initial segment &                      68 &                    19.1 &      3.555 &         3.7e$^{-17}$ &         3.7e$^{-13}$ \\
      metal ion transmembrane transporter activity &                      47 &                   9.459 &      4.969 &         3.7e$^{-17}$ &         3.8e$^{-13}$ \\
                                Rac GTPase binding &                      98 &                    35.5 &      2.760 &           4e$^{-17}$ &         4.1e$^{-13}$ \\
                            neutrophil aggregation &                      23 &                   1.602 &       14.4 &         4.2e$^{-17}$ &         4.3e$^{-13}$ \\
                               prolactin secretion &                      23 &                   1.602 &       14.4 &         4.2e$^{-17}$ &         4.3e$^{-13}$ \\
                      Toll-like receptor 4 binding &                      23 &                   1.602 &       14.4 &         4.2e$^{-17}$ &         4.3e$^{-13}$ \\
                              chemokine production &                      23 &                   1.602 &       14.4 &         4.2e$^{-17}$ &         4.3e$^{-13}$ \\
                            triglyceride transport &                      52 &                    11.6 &      4.467 &         4.4e$^{-17}$ &         4.5e$^{-13}$ \\
                 phospholipid transporter activity &                     121 &                    49.4 &      2.447 &         4.7e$^{-17}$ &         4.8e$^{-13}$ \\
             positive regulation of vesicle fusion &                      27 &                   2.584 &       10.4 &         4.8e$^{-17}$ &         4.9e$^{-13}$ \\
                                        sarcoplasm &                      47 &                   9.532 &      4.931 &         4.9e$^{-17}$ &           5e$^{-13}$ \\
              voltage-gated sodium channel complex &                      54 &                    12.6 &      4.290 &         5.3e$^{-17}$ &         5.4e$^{-13}$ \\
  organic anion transmembrane transporter activity &                      83 &                    27.2 &      3.052 &         5.3e$^{-17}$ &         5.4e$^{-13}$ \\
                       protein homotetramerization &                     143 &                    63.6 &      2.247 &         5.9e$^{-17}$ &           6e$^{-13}$ \\
     regulation of actin cytoskeleton organization &                     120 &                    49.1 &      2.445 &         6.7e$^{-17}$ &         6.8e$^{-13}$ \\
             regulation of membrane repolarization &                      33 &                   4.404 &      7.494 &         6.8e$^{-17}$ &           7e$^{-13}$ \\
                   sarcoplasmic reticulum membrane &                      94 &                    33.5 &      2.805 &         6.8e$^{-17}$ &           7e$^{-13}$ \\
 positive regulation of protein targeting to mi... &                     159 &                    74.5 &      2.134 &         8.4e$^{-17}$ &         8.6e$^{-13}$ \\
           ATP hydrolysis coupled proton transport &                      70 &                    20.5 &      3.413 &         8.5e$^{-17}$ &         8.7e$^{-13}$ \\
     establishment of body hair planar orientation &                      56 &                    13.7 &      4.095 &         8.9e$^{-17}$ &         9.1e$^{-13}$ \\
\end{longtable}
